Novartis AG NVS
i
Market datapartial · fetched 2026-11-11T14:32:17.585Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:32:15.849820957Z
FundamentalsAlpha Vantage · unavailable
Novartis AG options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 167.83 | 33.1% | 5.5% | 152.16 | 38.6% | 5.6% |
| 25Δ | 166.13 | 32.4% | 4.6% | 153.94 | 37.8% | 4.7% |
| 30Δ | 164.64 | 31.9% | 3.9% | 155.50 | 37.3% | 4.0% |
| 35Δ | 163.56 | 32.0% | 3.5% | 156.73 | 37.1% | 3.5% |
| 40Δ | 162.49 | 32.1% | 3.0% | 157.96 | 36.9% | 3.0% |
| 45Δ | 161.42 | 32.2% | 2.6% | 159.18 | 36.7% | 2.5% |
| 50Δ | 160.35 | 32.3% | 2.2% | 160.42 | 36.6% | 2.1% |
| 55Δ | 159.30 | 32.1% | 1.9% | 161.67 | 36.9% | 1.8% |
| 60Δ | 158.26 | 31.8% | 1.6% | 162.91 | 37.2% | 1.6% |
| 65Δ | 157.23 | 31.4% | 1.4% | 164.16 | 37.5% | 1.3% |
| 70Δ | 156.19 | 31.1% | 1.1% | 165.70 | 38.5% | 1.0% |
| 75Δ | 155.16 | 30.8% | 0.8% | 167.85 | 41.0% | 0.8% |
| 80Δ | 153.46 | 31.7% | 0.7% | 170.00 | 43.5% | 0.6% |
20Δ
- Pseudo strike
- 167.83
- IV
- 33.1%
- B/E move
- 5.5%
- Pseudo strike
- 152.16
- IV
- 38.6%
- B/E move
- 5.6%
25Δ
- Pseudo strike
- 166.13
- IV
- 32.4%
- B/E move
- 4.6%
- Pseudo strike
- 153.94
- IV
- 37.8%
- B/E move
- 4.7%
30Δ
- Pseudo strike
- 164.64
- IV
- 31.9%
- B/E move
- 3.9%
- Pseudo strike
- 155.50
- IV
- 37.3%
- B/E move
- 4.0%
35Δ
- Pseudo strike
- 163.56
- IV
- 32.0%
- B/E move
- 3.5%
- Pseudo strike
- 156.73
- IV
- 37.1%
- B/E move
- 3.5%
40Δ
- Pseudo strike
- 162.49
- IV
- 32.1%
- B/E move
- 3.0%
- Pseudo strike
- 157.96
- IV
- 36.9%
- B/E move
- 3.0%
45Δ
- Pseudo strike
- 161.42
- IV
- 32.2%
- B/E move
- 2.6%
- Pseudo strike
- 159.18
- IV
- 36.7%
- B/E move
- 2.5%
50Δ
- Pseudo strike
- 160.35
- IV
- 32.3%
- B/E move
- 2.2%
- Pseudo strike
- 160.42
- IV
- 36.6%
- B/E move
- 2.1%
55Δ
- Pseudo strike
- 159.30
- IV
- 32.1%
- B/E move
- 1.9%
- Pseudo strike
- 161.67
- IV
- 36.9%
- B/E move
- 1.8%
60Δ
- Pseudo strike
- 158.26
- IV
- 31.8%
- B/E move
- 1.6%
- Pseudo strike
- 162.91
- IV
- 37.2%
- B/E move
- 1.6%
65Δ
- Pseudo strike
- 157.23
- IV
- 31.4%
- B/E move
- 1.4%
- Pseudo strike
- 164.16
- IV
- 37.5%
- B/E move
- 1.3%
70Δ
- Pseudo strike
- 156.19
- IV
- 31.1%
- B/E move
- 1.1%
- Pseudo strike
- 165.70
- IV
- 38.5%
- B/E move
- 1.0%
75Δ
- Pseudo strike
- 155.16
- IV
- 30.8%
- B/E move
- 0.8%
- Pseudo strike
- 167.85
- IV
- 41.0%
- B/E move
- 0.8%
80Δ
- Pseudo strike
- 153.46
- IV
- 31.7%
- B/E move
- 0.7%
- Pseudo strike
- 170.00
- IV
- 43.5%
- B/E move
- 0.6%
Options history
Table
| Date | IV (%) |
|---|---|
| 25.45% | |
| 26.83% | |
| 25.66% | |
| 26.80% | |
| 26.77% | |
| 25.72% | |
| 24.61% | |
| 24.76% | |
| 25.17% | |
| 25.34% |
Drug Manufacturers - General
OGN
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine,…
More →PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →SNY
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The…
More →ABBV
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
More →AMGN
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular…
More →AMRN
Description unavailable
More →